BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35991837)

  • 1. Tumor-Derived Exosomal RNA From Fine-Needle Aspiration Supernatant as a Novel Liquid Biopsy for Molecular Diagnosis of Cancer.
    Li G; Liu D; Flandrin P; Zhang Y; Lambert C; Mallouk N; Cottier M
    Pathol Oncol Res; 2022; 28():1610344. PubMed ID: 35991837
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary Exosomal CA9 mRNA as a Novel Liquid Biopsy for Molecular Diagnosis of Bladder Cancer.
    Wen J; Yang T; Mallouk N; Zhang Y; Li H; Lambert C; Li G
    Int J Nanomedicine; 2021; 16():4805-4811. PubMed ID: 34285483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
    Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
    Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next-generation sequencing of thyroid nodules.
    Ye W; Hannigan B; Zalles S; Mehrotra M; Barkoh BA; Williams MD; Cabanillas ME; Edeiken-Monroe B; Hu P; Duose D; Wistuba II; Medeiros LJ; Stewart J; Luthra R; Roy-Chowdhuri S
    Cancer Cytopathol; 2019 Mar; 127(3):146-160. PubMed ID: 30620446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsy assay for lung carcinoma using centrifuged supernatants from fine-needle aspiration specimens.
    Hannigan B; Ye W; Mehrotra M; Lam V; Bolivar A; Zalles S; Barkoh BA; Duose D; Hu PC; Broaddus R; Stewart J; Heymach J; Medeiros LJ; Wistuba I; Luthra R; Roy-Chowdhuri S
    Ann Oncol; 2019 Jun; 30(6):963-969. PubMed ID: 30887015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and comparison of EGFR mutations from supernatants that contain cell-free DNA and cell pellets from FNA non-small cell lung cancer specimens.
    Wu W; Huang Y; Guo J; Xie X; Li H; Cao Z; Wei H; Wu C
    Cancer Cytopathol; 2020 Aug; 128(8):545-552. PubMed ID: 32286726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD63-GPC1-Positive Exosomes Coupled with CA19-9 Offer Good Diagnostic Potential for Resectable Pancreatic Ductal Adenocarcinoma.
    Buscail E; Chauvet A; Quincy P; Degrandi O; Buscail C; Lamrissi I; Moranvillier I; Caumont C; Verdon S; Brisson A; Marty M; Chiche L; Laurent C; Vendrely V; Moreau-Gaudry F; Bedel A; Dabernat S
    Transl Oncol; 2019 Nov; 12(11):1395-1403. PubMed ID: 31400579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel quantitative analysis of the S100P protein combined with endoscopic ultrasound-guided fine needle aspiration cytology in the diagnosis of pancreatic adenocarcinoma.
    Chiba M; Imazu H; Kato M; Ikeda K; Arakawa H; Kato T; Sumiyama K; Homma S
    Oncol Rep; 2017 Apr; 37(4):1943-1952. PubMed ID: 28260012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy of fine-needle aspiration supernatant for lung cancer genotyping.
    Guibert N; Tsukada H; Hwang DH; Chambers E; Cibas ES; Bale T; Supplee J; Ulrich B; Sholl LM; Paweletz CP; Oxnard GR
    Lung Cancer; 2018 Aug; 122():72-75. PubMed ID: 30032849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma.
    Li Z; Jiang P; Li J; Peng M; Zhao X; Zhang X; Chen K; Zhang Y; Liu H; Gan L; Bi H; Zhen P; Zhu J; Li X
    Oncogene; 2018 Jul; 37(28):3822-3838. PubMed ID: 29643475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer.
    Yang S; Che SP; Kurywchak P; Tavormina JL; Gansmo LB; Correa de Sampaio P; Tachezy M; Bockhorn M; Gebauer F; Haltom AR; Melo SA; LeBleu VS; Kalluri R
    Cancer Biol Ther; 2017 Mar; 18(3):158-165. PubMed ID: 28121262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA sequencing distinguishes benign from malignant pancreatic lesions sampled by EUS-guided FNA.
    Rodriguez SA; Impey SD; Pelz C; Enestvedt B; Bakis G; Owens M; Morgan TK
    Gastrointest Endosc; 2016 Aug; 84(2):252-8. PubMed ID: 26808815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucin expression pattern in pancreatic diseases: findings from EUS-guided fine-needle aspiration biopsies.
    Carrara S; Cangi MG; Arcidiacono PG; Perri F; Petrone MC; Mezzi G; Boemo C; Talarico A; Cin ED; Grassini G; Doglioni C; Testoni PA
    Am J Gastroenterol; 2011 Jul; 106(7):1359-63. PubMed ID: 21647207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal glypican-1 discriminates pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Moutinho-Ribeiro P; Adem B; Batista I; Silva M; Silva S; Ruivo CF; Morais R; Peixoto A; Coelho R; Costa-Moreira P; Lopes S; Vilas-Boas F; Durães C; Lopes J; Barroca H; Carneiro F; Melo SA; Macedo G
    Dig Liver Dis; 2022 Jul; 54(7):871-877. PubMed ID: 34840127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS mutation testing on all non-malignant diagnosis of pancreatic endoscopic ultrasound-guided fine-needle aspiration biopsies improves diagnostic accuracy.
    Trisolini E; Armellini E; Paganotti A; Veggiani C; Bozzola C; Frattini M; Pizio C; Mancuso G; Andorno S; Boldorini R
    Pathology; 2017 Jun; 49(4):379-386. PubMed ID: 28450086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Fine-Needle Biopsy vs Fine-Needle Aspiration in Diagnosis of Pancreatic and Abdominal Masses: A Prospective, Multicenter, Randomized Controlled Trial.
    Cheng B; Zhang Y; Chen Q; Sun B; Deng Z; Shan H; Dou L; Wang J; Li Y; Yang X; Jiang T; Xu G; Wang G
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1314-1321. PubMed ID: 28733257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine Needle Aspiration versus Fine Needle Biopsy of Biliopancreatic Lesions: Are They Really Opposing Techniques or Can They Be Complementary? Our Experience in a Large Cohort of Cases from a Single Institution.
    Nicola M; Onorati M; Albertoni MM; Bianchi CL; De Nucci G; Mandelli ED; Nicola L; Di Nuovo F
    Acta Cytol; 2021; 65(1):40-47. PubMed ID: 33099544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Cell-Free DNA to Assess Risk of Tumoremia Following Endoscopic Ultrasound Fine-Needle Aspiration of Pancreatic Adenocarcinomas.
    Levy MJ; Kipp BR; Milosevic D; Schneider AR; Voss JS; Avula R; Kerr SE; Henry MR; Highsmith E; Liu MC; Gleeson FC
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1632-1640.e1. PubMed ID: 29526691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma.
    Nakamura S; Sadakari Y; Ohtsuka T; Okayama T; Nakashima Y; Gotoh Y; Saeki K; Mori Y; Nakata K; Miyasaka Y; Onishi H; Oda Y; Goggins M; Nakamura M
    Ann Surg Oncol; 2019 Jul; 26(7):2104-2111. PubMed ID: 30820789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary study on the diagnostic value of serum-derived exosomal lncRNA in epithelial ovarian cancer].
    Li YW; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):198-209. PubMed ID: 35385957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.